Compare Stryker Corporation (SYK) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Stryker Corporation trades at $314.62 (market cap $122.35B), while State Street SPDR S&P Biotech ETF trades at $154.42. The key difference: Stryker Corporation pays a 1% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| SYK | XBI | |
|---|---|---|
Market Cap | $122.35B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $403.53 | $164.28 |
52-Week Low | $282.58 | $85.16 |
Enterprise Value | $134.10B | — |
Dividend Yield | 1% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
